Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07577219 · ClinicalTrials.gov registry record · NA
Vision Rehabilitation Training With Multimodal Feedback in Central Vision Loss
A NA study, sponsored by New England College of Optometry.
- Recruiting
- Registry status
- NA
- Development phase
- 12
- Enrollment target
NCT07577219 is a NA study that is actively recruiting participants, run by New England College of Optometry. The registered enrollment target is 12 participants.
The verdict
NCT07577219, a NA study, is actively recruiting participants, sponsored by New England College of Optometry.
- RECRUITING
- Registry status
- NA
- Development phase
- 12 participants
- Enrollment target
Study Summary
Central vision loss from macular degeneration creates blind spots that impair reading, face recognition, and navigation. Individuals must learn to use peripheral vision, requiring retraining of eye movements. Our preliminary research using high-speed eye tracking demonstrated that people with larger scotomas have impaired eye movement control, and that single-session visual feedback training showed limited immediate benefit, though combining feedback types showed promise. This study will evaluate whether extended binocular training (5 weekly sessions) with multimodal feedback improves eye movement control in 8-15 participants with bilateral central vision loss. Unlike conventional monocular rehabilitation systems, our approach trains both eyes simultaneously using real-time visual and auditory feedback during saccadic and smooth pursuit tasks. Participants will receive gaze-contingent scotoma awareness feedback, preferred retinal locus feedback, and auditory cues while performing eye tracking exercises. Primary outcomes include saccadic accuracy (latency, landing error, amplitude) and smooth pursuit parameters (gain, tracking accuracy). Secondary outcomes include contrast sensitivity and self-reported visual function. Success could establish an evidence base for accessible home-based training using virtual reality technology, potentially benefiting millions with macular degeneration.
Interventions
- BEHAVIORAL eccentric viewing training with biofeedback
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2026-01-31 |
| Est. Completion | 2026-12-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07577219
The ClinicalTrials.gov registry entry for NCT07577219 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is New England College of Optometry, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which eccentric viewing training with biofeedback is the first listed.
NCT07577219 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07577219 about?
NCT07577219 is a clinical study titled "Vision Rehabilitation Training With Multimodal Feedback in Central Vision Loss". Central vision loss from macular degeneration creates blind spots that impair reading, face recognition, and navigation. Individuals must learn to use peripheral vision, requiring retraining of eye movements. Our preliminary research using high-speed eye tracking demonstrated that people with larger...
What is the current status of trial NCT07577219?
This trial is currently recruiting. It is a NA study. The enrollment target is 12 participants. The study started on 2026-01-31. Estimated completion is 2026-12-01.
What interventions are being tested in trial NCT07577219?
The interventions under investigation include: eccentric viewing training with biofeedback (BEHAVIORAL).
Who is sponsoring clinical trial NCT07577219?
This trial is sponsored by New England College of Optometry, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.